The Problem: Neuroblastoma

Neuroblastoma is the most common cancer in infants. It is a solid tumor cancer that affects children. Every 14 hours, a child is diagnosed with the disease.

Although most kids get to remission, nearly half those kids relapse – and there’s no cure for relapsed neuroblastoma.

Our Goals

1) Measurably impact neuroblastoma survival every year.

2) Increase survival to greater than 90% by 2027.

3) Discover targeted drugs to decrease toxicity, increase quality of life, and increase long term (greater than 5 year) survival.


How We’re Beating Nb

We helped found and continue to fund a global research consortium called Beat Childhood Cancer. Through this consortium, research is happening in 40 hospitals and research institutions nationally, along with 8 international locations.

Our short term goal is preventing relapse and increasing survival using a drug called DFMO. In the long term, our work with precision medicine is helping us find existing FDA approved drugs targeting common pathways in neuroblastoma. Partnering with companies like Dell and other great organizations, the work we’re helping to fund is leading the genomics charge in childhood cancer, and has been since 2010.

Donate to Help KIDS Beat Cancer

Dedicate this Donation

Honoree Details

Notification Details

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

Donation Total: $25 One Time

Thank you!